Literature DB >> 28274615

Oxidative metabolism of curcumin-glucuronide by peroxidases and isolated human leukocytes.

Paula B Luis1, Odaine N Gordon1, Fumie Nakashima2, Akil I Joseph1, Takahiro Shibata2, Koji Uchida3, Claus Schneider4.   

Abstract

Conjugation with glucuronic acid is a prevalent metabolic pathway of orally administrated curcumin, the bioactive diphenol of the spice turmeric. The major in vitro degradation reaction of curcumin is autoxidative transformation resulting in oxygenation and cyclization of the heptadienedione chain to form cyclopentadione derivatives. Here we show that curcumin-glucuronide is much more stable than curcumin, degrading about two orders of magnitude slower. Horseradish peroxidase-catalyzed oxidation of curcumin-glucuronide occurred at about 80% of the rate with curcumin, achieving efficient transformation. Using LC-MS and NMR analyses the major products of oxidative transformation were identified as glucuronidated bicyclopentadione diastereomers. Cleavage into vanillin-glucuronide accounted for about 10% of the products. Myeloperoxidase and lactoperoxidase oxidized curcumin-glucuronide whereas tyrosinase and xanthine oxidase were not active. Phorbol ester-activated primary human leukocytes showed increased oxidative transformation of curcumin-glucuronide which was inhibited by the peroxidase inhibitor sodium azide. These studies provide evidence that the glucuronide of curcumin is not an inert product and may undergo further enzymatic and non-enzymatic metabolism. Oxidative transformation by leukocyte myeloperoxidase may represent a novel metabolic pathway of curcumin and its glucuronide conjugate.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoxidation; Bicyclopentadione; Curcumin; Curcumin (PubChem CID: 969516); Curcumin-d6 (PubChem CID: 53464495); Curcumin-glucuronide (PubChem CID: 92024088); Glucuronide; Myeloperoxidase; Peroxidase

Mesh:

Substances:

Year:  2017        PMID: 28274615      PMCID: PMC5390522          DOI: 10.1016/j.bcp.2017.03.002

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  45 in total

1.  Stability of curcumin in buffer solutions and characterization of its degradation products.

Authors:  Y J Wang; M H Pan; A L Cheng; L I Lin; Y S Ho; C Y Hsieh; J K Lin
Journal:  J Pharm Biomed Anal       Date:  1997-08       Impact factor: 3.935

2.  Unraveling curcumin degradation: autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione.

Authors:  Odaine N Gordon; Paula B Luis; Herman O Sintim; Claus Schneider
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

Review 3.  Curcumin uptake and metabolism.

Authors:  Manfred Metzler; Erika Pfeiffer; Simone I Schulz; Julia S Dempe
Journal:  Biofactors       Date:  2012-09-20       Impact factor: 6.113

4.  Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells.

Authors:  Jia-Ching Wu; Ching-Shu Lai; Vladimir Badmaev; Kalyanam Nagabhushanam; Chi-Tang Ho; Min-Hsiung Pan
Journal:  Mol Nutr Food Res       Date:  2011-09-19       Impact factor: 5.914

5.  Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

Authors:  C Ireson; S Orr; D J Jones; R Verschoyle; C K Lim; J L Luo; L Howells; S Plummer; R Jukes; M Williams; W P Steward; A Gescher
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  Metabolic activation of eugenol by myeloperoxidase and polymorphonuclear leukocytes.

Authors:  D Thompson; D Constantin-Teodosiu; K Norbeck; B Svensson; P Moldéus
Journal:  Chem Res Toxicol       Date:  1989 May-Jun       Impact factor: 3.739

7.  Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.

Authors:  James M Pauff; Russ Hille
Journal:  J Nat Prod       Date:  2009-04       Impact factor: 4.050

Review 8.  Mammalian heme peroxidases: from molecular mechanisms to health implications.

Authors:  Michael J Davies; Clare L Hawkins; David I Pattison; Martin D Rees
Journal:  Antioxid Redox Signal       Date:  2008-07       Impact factor: 8.401

Review 9.  Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase.

Authors:  Tomoko Nishino; Ken Okamoto; Bryan T Eger; Emil F Pai; Takeshi Nishino
Journal:  FEBS J       Date:  2008-05-30       Impact factor: 5.542

Review 10.  Mode of action of lactoperoxidase as related to its antimicrobial activity: a review.

Authors:  F Bafort; O Parisi; J-P Perraudin; M H Jijakli
Journal:  Enzyme Res       Date:  2014-09-16
View more
  11 in total

1.  Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues.

Authors:  Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Paula B Luis; Claus Schneider; Janet L Funk
Journal:  J Nutr Biochem       Date:  2018-10-11       Impact factor: 6.048

2.  Curcuminoid Content and Safety-Related Markers of Quality of Turmeric Dietary Supplements Sold in an Urban Retail Marketplace in the United States.

Authors:  Meghan B Skiba; Paula B Luis; Chelsea Alfafara; Dean Billheimer; Claus Schneider; Janet L Funk
Journal:  Mol Nutr Food Res       Date:  2018-05-29       Impact factor: 5.914

3.  A Curcumin Degradation Product, 7-Norcyclopentadione, Formed by Aryl Migration and Loss of a Carbon from the Heptadienedione Chain.

Authors:  Akil I Joseph; Paula B Luis; Claus Schneider
Journal:  J Nat Prod       Date:  2018-12-18       Impact factor: 4.050

4.  The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites.

Authors:  Rebecca L Edwards; Paula B Luis; Paolo V Varuzza; Akil I Joseph; Sai Han Presley; Rupesh Chaturvedi; Claus Schneider
Journal:  J Biol Chem       Date:  2017-11-02       Impact factor: 5.157

5.  Stability and anti-inflammatory activity of the reduction-resistant curcumin analog, 2,6-dimethyl-curcumin.

Authors:  Akil I Joseph; Rebecca L Edwards; Paula B Luis; Sai Han Presley; Ned A Porter; Claus Schneider
Journal:  Org Biomol Chem       Date:  2018-05-02       Impact factor: 3.876

6.  Beta-Glucuronidase Catalyzes Deconjugation and Activation of Curcumin-Glucuronide in Bone.

Authors:  Andrew G Kunihiro; Paula B Luis; Julia A Brickey; Jen B Frye; H-H Sherry Chow; Claus Schneider; Janet L Funk
Journal:  J Nat Prod       Date:  2019-02-22       Impact factor: 4.050

7.  Curcumin Inhibition of TGFβ signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites.

Authors:  Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Julia N Cheng; Paula B Luis; Claus Schneider; Janet L Funk
Journal:  J Nutr Biochem       Date:  2021-08-15       Impact factor: 6.048

8.  Incomplete Hydrolysis of Curcumin Conjugates by β-Glucuronidase: Detection of Complex Conjugates in Plasma.

Authors:  Paula B Luis; Andrew G Kunihiro; Janet L Funk; Claus Schneider
Journal:  Mol Nutr Food Res       Date:  2020-01-29       Impact factor: 5.914

9.  Curcumin induces secretion of glucagon-like peptide-1 through an oxidation-dependent mechanism.

Authors:  Abdul-Musawwir Alli-Oluwafuyi; Paula B Luis; Fumie Nakashima; Juan A Giménez-Bastida; Sai Han Presley; Matthew T Duvernay; Ezekiel O Iwalewa; Claus Schneider
Journal:  Biochimie       Date:  2019-08-27       Impact factor: 4.079

10.  Curcumin Oxidation Is Required for Inhibition of Helicobacter pylori Growth, Translocation and Phosphorylation of Cag A.

Authors:  Ashwini Kumar Ray; Paula B Luis; Surabhi Kirti Mishra; Daniel P Barry; Mohammad Asim; Achyut Pandey; Maya Chaturvedi; Jyoti Gupta; Shilpi Gupta; Shweta Mahant; Rajashree Das; Pramod Kumar; Keith T Wilson; Claus Schneider; Rupesh Chaturvedi
Journal:  Front Cell Infect Microbiol       Date:  2021-12-24       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.